Details of the Drug Combinations

General Information of This Drug (ID: DMNGT5Q)

Drug Name

Ypeginterferon alfa-2a DMNGT5Q

Synonyms

Ypeginterferon alfa-2a (chronic hepatitis B) Amoytop; Ypeginterferon alfa-2a (chronic hepatitis C) Amoytop; YPEG-rhIFNalpha-2a (chronic hepatitis B/chronic hepatitis C infection), Amoytop

Indication

Disease Entry	ICD 11	Status	REF
Hepatitis B virus infection	1E51.0	Phase 3	[1]
------------------------------------------------------------------------------------

List of Combinatorial Drugs (CBD) Containing This Drug

1 Investigative Drug Combination(s) Consisting of This drug

Normalized Drug Combination Synergy Score

Synergy scores were normalized using Min-Max Scaling to facilitate visual comparisons.

DrugCom Name	DrugCom ID	Component Drug	Indication	REF
Ribavirin + Ypeginterferon alfa-2a	DCRBJDI	Ribavirin	Middle East Respiratory Syndrome (MERS) (Cell Line: .)	[2]
------------------------------------------------------------------------------------

References

1	ClinicalTrials.gov (NCT01581398) Efficacy and Safety Study of Peginterferon Alfa-2b in Chinese Chronic Hepatitis C Patients. U.S. National Institutes of Health.
2	SARS and MERS: recent insights into emerging coronaviruses. Nat Rev Microbiol. 2016 Aug;14(8):523-34.